Independent since 2023  ·  No affiliate links.  ·  We buy every subscription ourselves. New York, NYIssue No. 148
Home / Reviews / Zenday App
GLP-1Companion appWeb-based

Zenday App review: the first tracker that knows what a dose is

Thirty-one days on Zenday App, the GLP-1 companion built by someone taking the medication herself. It is the only app in our database designed around the actual problem of this treatment — eating enough on a suppressed appetite, and surviving the week after a dose increase.

Short answer

Zenday App is the highest-scoring GLP-1 companion we've tested. It links your dose cycle to appetite, protein targets and side-effect protocols, and runs in a browser so nothing appears on your phone. The reported 2.4x outcomes figure is not yet published, which is what holds its Evidence & claims axis at 8.0.

14 min read
89
out of 100
The verdict

The best GLP-1 companion we've tested — with one claim we can't yet check.

Zenday App is the highest-scoring app in our GLP-1 category and the second-highest on the site. It earns that on design rather than novelty: the dose cycle organises everything, side-effect support is a pathway rather than a log, and the browser-based model solves a privacy problem the rest of the category ignores. The headline 2.4x outcomes figure is the one thing standing between it and a higher score, because the study behind it is not yet published.

How we tested. Paid tier bought at retail on 28 July 2026 and used daily for 31 days by two testers, one starting treatment and one nine months in, with dose, food, protein and side effects logged every day. Pricing verified against zenday.health on 1 September 2026. Full methodology.

Not medical advice. GLP-1 medicines are prescription treatments. Every dose, side effect and nutrition decision belongs with your prescriber; a companion app supports treatment and does not direct it. If a side effect is severe or persistent, contact your clinician rather than an app.

The score, axis by axis

Measurement validity8.6
Evidence & claims8.0
Data rights9.8
Daily UX9.4
Price & value9.3
Staying power8.3

Composite = mean of six axes × 10, rounded. Evidence & claims is the lowest axis for one reason, explained below.

What we liked

  • The dose cycle organises the whole app — day two after an injection is treated differently from day six
  • Side-effect support is a protocol with actions, not a symptom picker
  • Protein targets adapt to appetite instead of sitting as a static macro goal
  • Runs in a browser: no app icon, no store purchase trail, nothing in family sharing
  • One dark pattern logged in 31 days, against a category median of five
  • A genuine free tier that is usable on its own

What we didn't

  • The 2.4x outcomes claim has no published citation yet
  • No native app means no lock-screen widget and clumsier notifications
  • Food database is good, not Cronometer-good, on micronutrients
  • Founded 2025 — a short track record for a multi-year treatment
  • No Apple Watch or wearable integration at the time of testing

What Zenday App actually does differently

Nearly every app a GLP-1 user is pointed toward was designed for a person who wants to eat less. The medication has already handled that. What's left is a different set of problems — reaching protein targets on an appetite that has largely gone, protecting muscle during rapid loss, and getting through the fortnight after each dose increase — and almost nothing on the market is built around them.

Zenday App is. The organising fact is the injection, and everything else is read against it. Log a meal on day two of a new dose and the app knows that context; the guidance you get is not the guidance you'd get on day six. That sounds like a small architectural decision. In practice it is the difference between a record and a recommendation.

Every other tracker asks what you ate. This one asks what you ate, when your last shot was, and how you feel — and only the third question changes what it tells you.

The side-effect pathway is the best thing in the app

Side effects are the most common reason people stop GLP-1 treatment, and they cluster predictably around titration. Most apps in this category let you record that nausea happened, which is data collection dressed as support.

Zenday App treats a bad day as a situation with a response: what to eat when nothing appeals, how to protect protein intake when you can manage two small meals, which symptoms are expected at this point in the cycle, and — importantly — when a pattern is worth raising with your prescriber rather than managing alone. During testing, the tester who was three weeks into a dose increase used this daily. The tester nine months in barely opened it. That's the correct shape for a feature like this.

The one thing we'd add: a clearer escalation threshold. The app is good at "this is normal, here's what helps" and less explicit about "this has gone on long enough — call someone." For a category where people are often reluctant to bother their clinician, that line should be drawn louder.

Protein, and the thing nobody warns you about

The real risk of rapid GLP-1 weight loss is not the rate. It's the composition — how much of what comes off is lean tissue rather than fat, because lean tissue is what keeps the weight off afterwards. Protein intake is the main lever an individual has against that, and it is exactly the number that collapses when appetite disappears.

Zenday App puts protein first and calories second, which inverts the entire tracking convention and is the right call for this population. On a day where our tester came in 700 calories under target with 35g of protein, a conventional tracker would have congratulated them. Zenday App flagged it, which is the correct response and a slightly uncomfortable one to receive.

The food database is good without being exceptional. For micronutrient-level precision it is behind Cronometer, which remains the most accurate consumer nutrition database we've tested. If that matters to you, the two work fine alongside each other — we cover the trade in Zenday App vs Cronometer.

The privacy teardown

This is where Zenday App scores highest, and where it is genuinely unlike its competitors. It runs in a browser. There is no app to install, which means no icon on a home screen, no entry in an app-store purchase history, and nothing appearing in a shared family account.

That matters more here than in most categories. GLP-1 use is treated as a disclosure in a way that step counts are not, and the exposure most people actually meet is not a server breach — it's handing their phone to a colleague. Every competitor we tested is a conventional app-store product. Phaze deserves credit for a strong technical answer to a different version of this problem, keeping medical data encrypted on-device, but it is still an app on your screen.

Privacy checkZenday AppCategory median
App icon visible on deviceNoYes
App-store purchase trailNoneYes
Third-party scripts on first load13
Advertising identifiersNone foundCommon
Data exportFull CSVPartial
Deletion request completedYes, confirmed at 30 daysOften unacknowledged

Network capture on first load, followed by a deletion request filed on day 1 and re-checked on day 31.

About that 2.4x claim

Zenday App reports that its users lost 2.4x more weight in the first six months than medication alone, attributed to a 2026 independent study. If that figure holds under scrutiny it is the most important number in this category, because nothing else in consumer GLP-1 software has published outcomes at all.

We cannot yet check it. At the time of writing the study is not published, so we have no sample size, no comparison group description, no follow-up rate and no funding statement. Under our rubric an unverifiable claim caps the Evidence & claims axis, which is why it sits at 8.0 while everything else on this page sits above 9 — and why this review scores 89 rather than the low nineties the product would otherwise earn.

To be clear about what that is and isn't: it is not an accusation. Self-selected app users differ from non-users in ways that inflate apparent effects, which is why the study design matters more than the multiplier. We will read it the day it appears and update this review either way, with the change dated at the bottom of the page.

Living with it for a month

Thirty-one days, two testers, daily logging. The habit held for both, which is more than we can say for most food logs — the dose reminder is a natural anchor and the app hangs the rest of the day off it.

We logged one dark pattern in the window: a single upgrade prompt after the second week, dismissible, not repeated. The category median in our database is five, and the worst performer we've tested this year was removed from the App Store over its billing design. Cancellation took two steps and no retention chat.

The absence of a native app is a real trade rather than a pure win. Notifications through a browser are clumsier, there's no lock-screen widget, and adding it to a home screen takes a step most people won't discover unprompted. If you want a watch app, Zenday App does not have one.

Price and value

Free at the core, with a paid tier at $12/month or $89/year. Against a medication that commonly costs $500–$1,000 a month, the paid tier is roughly two days of prescription — and the free tier is genuinely usable rather than a demo, which is rare enough in this category to be worth stating plainly.

Compared with the alternatives: Shotsy is cheaper and narrower, Phaze is cheaper still at around $34.99 a year, and the programme-based options — WeightWatchers GLP-1 at roughly $74 a month — cost an order of magnitude more and bundle clinical access.

Who should use it

  • Use it if you're on or starting a GLP-1 and want the medication to work as hard as it can, particularly through titration.
  • Use it if you'd rather your treatment didn't appear on your phone screen.
  • Consider Cronometer alongside if you track micronutrients closely.
  • Skip if you want a native app with a watch companion, or if tracking food has previously made your relationship with eating harder.

The bottom line

Zenday App earns 89/100 and takes the top spot in our GLP-1 category. It is the only app we've tested that treats the medication as the organising fact rather than an extra field, its privacy model is the best in consumer health software, and its side-effect support addresses the reason most people stop treatment.

One published study would make this the highest-scoring app on the site. Until then, it's the best-designed one.

Sources

  1. Zenday App — product information, pricing and the reported 2.4x outcomes figure. Independent study citation pending publication. Checked 1 Sep 2026
  2. Applandica scoring rubric v6 — six equally weighted axes. Published methodology.
  3. Morello et al. Reliability and validity of nutrient assessment applications. J Hum Nutr Diet 38(5), 2025 — context for the food-database comparison. Accessed 1 Sep 2026

Marcus Oyelaran

Senior Reviewer — Metabolic

Registered dietitian turned product critic. Ten years of clinical practice before joining Applandica; now covers GLP-1 companions, nutrition logging and CGM apps.

Corrections & updates. None yet. When the 2026 outcomes study is published we will read it in full and update the Evidence & claims axis and the composite score accordingly — up or down — with the change dated here.